221 related articles for article (PubMed ID: 8435382)
1. Torasemide in the treatment of patients with cirrhosis and ascites.
Gentilini P; Laffi G; La Villa G; Carloni V; Foschi M; Romanelli RG; Marra F
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():81-5. PubMed ID: 8435382
[TBL] [Abstract][Full Text] [Related]
2. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial.
Gerbes AL; Bertheau-Reitha U; Falkner C; Jüngst D; Paumgartner G
J Hepatol; 1993 Mar; 17(3):353-8. PubMed ID: 8315263
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
[TBL] [Abstract][Full Text] [Related]
4. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between torasemide and furosemide in the treatment of ascites in cirrhotic patients].
Marelli A; Bodini P; Reggiani A; Quinzani M; Dizioli P; Tonghini L
Minerva Med; 1997 Mar; 88(3):109-15. PubMed ID: 9148226
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
[TBL] [Abstract][Full Text] [Related]
7. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
8. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
[TBL] [Abstract][Full Text] [Related]
9. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.
Abecasis R; Guevara M; Miguez C; Cobas S; Terg R
Scand J Gastroenterol; 2001 Mar; 36(3):309-13. PubMed ID: 11305520
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of torasemide and furosemide in liver cirrhosis.
Fiaccadori F; Pasetti GC; Pedretti G; Pizzaferri P; Elia GF
Cardiology; 1994; 84 Suppl 2():80-6. PubMed ID: 7954549
[TBL] [Abstract][Full Text] [Related]
12. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
Angeli P; Fasolato S; Mazza E; Okolicsanyi L; Maresio G; Velo E; Galioto A; Salinas F; D'Aquino M; Sticca A; Gatta A
Gut; 2010 Jan; 59(1):98-104. PubMed ID: 19570764
[TBL] [Abstract][Full Text] [Related]
13. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Brunner G; von Bergmann K; Häcker W; von Möllendorff E
Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
[TBL] [Abstract][Full Text] [Related]
14. Stepped care medical treatment for cirrhotic ascites: analysis of factors influencing the response to treatment.
Takaya A; Fukui H; Matsumura M; Uemura M; Kojima H; Okamoto S; Tsujii T
J Gastroenterol Hepatol; 1995; 10(1):30-5. PubMed ID: 7620104
[TBL] [Abstract][Full Text] [Related]
15. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
Dunn CJ; Fitton A; Brogden RN
Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
[TBL] [Abstract][Full Text] [Related]
16. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS
Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838
[TBL] [Abstract][Full Text] [Related]
17. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Lowenthal DT; Shear L
Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
[No Abstract] [Full Text] [Related]
18. [Effects of various diuretics on cardiac function in rats with heart failure].
Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
[TBL] [Abstract][Full Text] [Related]
19. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
Knauf H; Mutschler E
Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
[TBL] [Abstract][Full Text] [Related]
20. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
